The Valley Desk

ArticleNutrition, metabolism, and cardiovascular diseases : NMCDPublished

Impact of empagliflozin as add-on to metformin vs metformin continuation on MASLD progression in type 2 diabetes: The IMAGIN Study

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Temple University. Affiliation source

Publication record

Type
Article
Venue
Nutrition, metabolism, and cardiovascular diseases : NMCD
Published
Subject terms
Humans; Liver Cirrhosis; Diabetes Mellitus, Type 2; Disease Progression; Metformin; Benzhydryl Compounds; Glucosides; Blood Glucose; MicroRNAs; Hypoglycemic Agents; Treatment Outcome; Drug Therapy, Combination
PubMed ID
40935714
Added to directory
Source checked

Report a correction or request removal